Interestingly, in a subsequent study these workers found that loss of TP53, in addition to oncogenic MET expression, was associated with the formation of tumours with a claudin-low profile, a recently described subgroup of TN tumours that is distinct from the BL subtype [83,86]. The gene discussed is MET; the disease is neoplasm.